Search
Products
Community
Markets
News
Brokers
More
IN
Get started
Markets
/
USA
/
Stocks
/
Health Technology
/
Medical Specialties
/
NXLIW
Nexalin Technology, Inc.
NXLIW
Nasdaq Stock Market
NXLIW
Nasdaq Stock Market
NXLIW
Nasdaq Stock Market
NXLIW
Nasdaq Stock Market
Market closed
Market closed
No trades
See on Supercharts
Overview
Financials
News
Discussions
Seasonals
NXLIW
chart
Full chart
1 day
5 days
1 month
6 months
Year to date
1 year
5 years
All time
Key
stats
Market capitalization
38.18 M
USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.6420
USD
Net income (FY)
−4.65 M
USD
Revenue (FY)
110.75 K
USD
Shares float
10.41 M
Beta (1Y)
−6.26
About Nexalin Technology, Inc.
Sector
Health Technology
Industry
Medical Specialties
CEO
Mark White
Website
nexalin.com
Headquarters
Houston
Founded
2010
FIGI
BBG019PNG7D4
Nexalin Technology, Inc. designs and develops neurostimulation products. Its medical devices helps people with mental health illness. The company was founded by John Patrick Claude on October 19, 2010 and is headquartered in Houston, TX.
Show more
Financials
Performance
Annual
Annual
Quarterly
Quarterly
More
More
Revenue to profit
conversion
Annual
Annual
Quarterly
Quarterly
More
More
Debt level and
coverage
Annual
Annual
Quarterly
Quarterly
More
More
Earnings
Next:
—
Annual
Annual
Quarterly
Quarterly
More
More
NXLIW
news
Seasonals
Displays a symbol's price movements over previous years to identify recurring trends.